Αποτελέσματα Αναζήτησης
This article explores the relationship between inflammation and cancer with an emphasis on epidemiological evidence, summarizes the current use of anti-inflammatory agents for cancer prevention and therapy, and describes the mechanisms underlying the anti-cancer effects of anti-inflammatory agents.
8 Δεκ 2021 · In this review, we present concise evidence-based recommendations for use of premedications aimed at assisting clinicians in their everyday decision-making for commonly used anticancer regimens.
26 Ιουν 2023 · Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side...
18 Δεκ 2023 · Nonsteroidal anti-inflammatory drugs including aspirin, piroxicam, diclofenac, ketorolac, and the antidepressant medicine imipramine, may be at least as efficacious as opioids for moderate-to-severe background cancer pain.
All three clinical trials demonstrated that semaglutide (injected or oral) has superior efficacy compared with placebo and other antidiabetic medications in weight reduction, which led to Food and Drug Administration approval of Wegovy (semaglutide) for weight loss. Keywords: obesity, diabetes mellitus, glucagon-like peptide 1.
Additionally, we review the evidence of four recent clinical trials, two systematic reviews, and two meta-analyses describing the efficacy of GLP-1 agonists in decreasing weight, lowering HbA1c, and improving obesity comorbidities.
12 Ιαν 2023 · When used in conjunction with diet and exercise, it can cause significant weight loss — and a reduced risk of cancer, diabetes and heart disease — in people who are obese or overweight. Semaglutide injections for weight loss. Currently, semaglutide is only approved for weight loss under the brand name Wegovy.
